Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free CTXR Stock Alerts $0.82 +0.07 (+8.86%) (As of 05:12 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Citius Pharmaceuticals Stock Price Performance5 Day Performance+0.19%1 Month Performance+7.18%3 Month Performance+3.15%6 Month Performance+7.52%Year-To-Date Performance+4.34%1 Year Performance-52.16% Receive CTXR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad DTIStart loving Mondays like thisWouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!Weekend after weekend! CTXR Stock Chart for Wednesday, April, 17, 2024 CTXR Chart by TradingView Citius Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/16/2024$0.77$0.75-2.01%$0.76$0.73482,635 shs$119.29 million04/15/2024$0.79$0.77-2.87%$0.79$0.75724,923 shs$121.74 million04/12/2024$0.83$0.79-5.45%$0.83$0.78625,548 shs$125.34 million04/11/2024$0.85$0.83-2.00%$0.89$0.70876,345 shs$132.56 million04/10/2024$0.89$0.85-4.50%$0.88$0.83828,642 shs$135.27 million04/09/2024$0.96$0.89-7.36%$0.97$0.86888,899 shs$141.65 million Get the Latest News and Ratings for CTXR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/08/2024$1.00$0.96-3.84%$1.00$0.95513,187 shs$152.90 million04/05/2024$0.95$1.00+5.40%$1.02$0.90921,431 shs$159.01 million04/04/2024$0.96$0.95-1.73%$0.99$0.921.48 million shs$150.86 million04/03/2024$0.98$0.96-1.20%$1.01$0.96964,613 shs$153.52 million04/02/2024$1.03$0.98-5.18%$1.07$0.931.72 million shs$155.38 million04/01/2024$0.90$1.03+14.79%$1.07$0.911.79 million shs$163.87 million03/29/2024$0.90$0.90$0.93$0.811.28 million shs$142.76 million03/28/2024$0.82$0.90+8.88%$0.93$0.811.28 million shs$142.76 million03/27/2024$0.80$0.82+2.82%$0.83$0.78460,219 shs$131.11 million03/26/2024$0.80$0.80-0.06%$0.82$0.78565,107 shs$127.52 million03/25/2024$0.79$0.80+1.75%$0.84$0.78803,417 shs$127.60 million03/22/2024$0.75$0.79+5.05%$0.79$0.72705,553 shs$125.40 million03/21/2024$0.78$0.75-3.32%$0.78$0.74570,644 shs$119.37 million03/20/2024$0.74$0.78+4.47%$0.78$0.73470,272 shs$123.48 million03/19/2024$0.72$0.74+3.15%$0.75$0.72425,294 shs$118.20 million03/18/2024$0.74$0.72-2.20%$0.80$0.701.09 million shs$114.58 million03/15/2024$0.69$0.74+6.91%$0.74$0.681.61 million shs$117.16 million03/14/2024$0.72$0.69-4.37%$0.73$0.68544,542 shs$109.59 million03/13/2024$0.69$0.72+3.74%$0.73$0.71380,803 shs$114.60 million03/12/2024$0.72$0.69-3.57%$0.74$0.65871,763 shs$110.46 million03/11/2024$0.75$0.72-3.56%$0.75$0.72305,741 shs$114.55 million03/08/2024$0.75$0.75+0.08%$0.78$0.73432,065 shs$118.78 million03/07/2024$0.72$0.75+4.34%$0.75$0.72308,561 shs$118.69 million03/06/2024$0.73$0.72-2.20%$0.77$0.70516,591 shs$113.76 million03/05/2024$0.77$0.73-4.53%$0.78$0.73577,924 shs$116.32 million03/04/2024$0.78$0.77-1.49%$0.80$0.76314,533 shs$121.84 million03/01/2024$0.77$0.78+1.18%$0.80$0.76319,259 shs$123.68 million02/29/2024$0.79$0.77-2.23%$0.82$0.76438,332 shs$122.24 million02/28/2024$0.75$0.79+4.30%$0.80$0.75428,961 shs$125.02 million02/27/2024$0.74$0.75+1.67%$0.76$0.74413,658 shs$119.87 million02/26/2024$0.76$0.74-2.50%$0.80$0.74540,829 shs$117.89 million02/23/2024$0.79$0.76-3.80%$0.79$0.76414,174 shs$120.92 million02/22/2024$0.77$0.79+2.61%$0.80$0.76396,104 shs$125.69 million02/21/2024$0.75$0.77+2.65%$0.78$0.74388,901 shs$122.49 millionUncover this 2024 Hidden Gem (Ad)Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.[Click here to subscribe] and elevate your trading today.02/20/2024$0.80$0.75-5.67%$0.78$0.73868,520 shs$119.33 million02/19/2024$0.80$0.80$0.86$0.771.22 million shs$126.50 million02/16/2024$0.84$0.80-5.60%$0.86$0.771.22 million shs$126.40 million02/15/2024$0.77$0.84+9.12%$0.84$0.761.04 million shs$133.90 million02/14/2024$0.68$0.77+13.51%$0.78$0.711.03 million shs$122.71 million02/13/2024$0.72$0.68-5.12%$0.74$0.67778,191 shs$108.10 million02/12/2024$0.66$0.72+8.92%$0.74$0.631.13 million shs$113.93 million02/09/2024$0.61$0.66+7.57%$0.67$0.60560,618 shs$104.60 million02/08/2024$0.61$0.61$0.63$0.61578,003 shs$97.24 million02/07/2024$0.61$0.61+0.23%$0.64$0.60564,287 shs$97.24 million02/06/2024$0.60$0.61+1.72%$0.62$0.60687,979 shs$97.02 million02/05/2024$0.63$0.60-4.09%$0.65$0.60672,014 shs$95.38 million02/02/2024$0.64$0.63-1.76%$0.65$0.62346,199 shs$99.45 million02/01/2024$0.62$0.64+2.54%$0.65$0.62619,972 shs$101.23 million01/31/2024$0.63$0.62-0.64%$0.64$0.62433,367 shs$98.72 million01/30/2024$0.67$0.63-6.54%$0.72$0.62796,436 shs$99.36 million01/29/2024$0.68$0.67-1.69%$0.72$0.651.49 million shs$106.30 million01/26/2024$0.65$0.68+4.15%$0.69$0.66308,149 shs$108.13 million01/25/2024$0.64$0.65+2.03%$0.68$0.63510,175 shs$103.82 million01/24/2024$0.67$0.64-4.97%$0.68$0.611.40 million shs$101.76 million01/23/2024$0.70$0.67-3.77%$0.71$0.66793,637 shs$107.08 million01/22/2024$0.72$0.70-2.91%$0.74$0.67924,995 shs$111.28 million01/19/2024$0.75$0.72-3.87%$0.76$0.72675,552 shs$114.62 million01/18/2024$0.77$0.75-1.99%$0.79$0.741.39 million shs$119.23 million01/17/2024$0.75$0.77+2.03%$0.78$0.74850,098 shs$121.64 million01/16/2024$0.75$0.75$0.76$0.74433,298 shs$119.23 million Related Companies: COYA Stock Chart SCTL Stock Chart OPTN Stock Chart IMUX Stock Chart RPTX Stock Chart ADAG Stock Chart NVCT Stock Chart VTGN Stock Chart CTMX Stock Chart ELYM Stock Chart Receive CTXR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTXR) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners#1 Crypto of 2024True Market Insiders[Urgent!] Generational Wealth GameplanCrypto 101 MediaTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsNew Trump BombshellThe Freeport SocietyAI healthcare stock poised for 36,996% growth?Behind the MarketsA.I. Pioneer Issues Urgent Warning to AmericansTradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.